These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6928226)

  • 1. Opposite effects of different strains or batches of same strain of BCG on in vitro generation of syngeneic and allogeneic antitumor cytotoxicity.
    Mokyr MB; Bennett JA; Braun DP; Hengst JC; Mitchell MS; Dray S
    J Natl Cancer Inst; 1980 Feb; 64(2):339-44. PubMed ID: 6928226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of anti-MOPC-315 cytotoxicity in uneducated or in vitro educated spleen cells from normal or MOPC-315 tumor-bearing mice pretreated in vivo with Bacillus Calmette-Guérin.
    Braun DP; Mokyr MB; Dray S
    Cancer Res; 1978 Jun; 38(6):1626-32. PubMed ID: 647676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of BCG on alloimmune cell-mediated cytotoxicity in (C57BL/6Jfemale x A/Jmale)F1 mice. II. Correlation with BCG activity in syngeneic tumor systems.
    Davies M; Sabbadini E
    J Natl Cancer Inst; 1978 May; 60(5):1069-73. PubMed ID: 305966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of BCG on alloimmune cell-mediated cytotoxicity in (C57BL/6Jfemale x A/Jmale)F1 mice. I. Effect of different BCG treatments on cytotoxicity mediated by T-cells and macrophages.
    Davies M; Sabbadini E
    J Natl Cancer Inst; 1978 May; 60(5):1059-68. PubMed ID: 305965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different doses of BCG on an allogeneic cell-mediated antitumor response in mice.
    Davies M; Sabbadini E
    J Natl Cancer Inst; 1977 Jul; 59(1):263-5. PubMed ID: 875058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of cell-mediated alloimmunity by BCG. I. Antagonism and potentiation of immunosuppression caused by cytarabine.
    Murahata RI; Mitchell MS
    J Natl Cancer Inst; 1982 Sep; 69(3):607-12. PubMed ID: 6981020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro induction of cell-mediated immunity to murine leukemia cells. III. Effect of methanol extraction residue fraction of BCG on the generation of cytotoxic lymphocytes against leukemia.
    Kedar E; Nahas F; Unger E; Weiss DW
    J Natl Cancer Inst; 1978 May; 60(5):1097-106. PubMed ID: 147948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bacille Calmette-Guérin on the immune response of BALB/c mice to a tumor allograft.
    Treagan L; Chen TH; Rambo O; Elberg SS
    J Infect Dis; 1979 Oct; 140(4):541-5. PubMed ID: 117062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.
    de Jong WH; Steerenberg PA; Kreeftenberg JG; Tiesjema RH; Kruizinga W; van Noorle Jansen LM; Ruitenberg EJ
    Cancer Immunol Immunother; 1984; 17(1):18-27. PubMed ID: 6563941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of BCG vaccine on neoplastic proliferation and host immune responses.
    Hakim AA; Grand NG
    J Pharm Sci; 1976 Mar; 65(3):339-43. PubMed ID: 1263078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro.
    Klimpel GR; Henney CS
    J Immunol; 1978 Feb; 120(2):563-9. PubMed ID: 304460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG induced murine peritoneal exudate cells: cytotoxic activity against a syngeneic bladder tumor cell line.
    Pang AS; Morales A
    J Urol; 1982 Jun; 127(6):1225-9. PubMed ID: 7087042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonspecific resistance to tumor allograft.
    Rejthar A; Wotke J; Rejtharová A; Jasková J
    Neoplasma; 1975; 22(3):273-8. PubMed ID: 1099469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant and antitumor activities of Nocardia cell-wall skeletons.
    Azuma I; Taniyama T; Yamawaki M; Sugimura K; Yamamura Y
    Gan; 1976 Oct; 67(5):733-6. PubMed ID: 797626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antitumor effects of BCG and monoclonal antibodies capable of inducing antibody-dependent cell-mediated cytotoxicity.
    Komuta K; Kawase I; Ogura T; Masuno T; Yokota S; Hosoe S; Ikeda T; Shirasaka T; Kishimoto S
    Jpn J Cancer Res; 1987 Feb; 78(2):185-92. PubMed ID: 3104261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective mobilization of specifically cytotoxic T-lymphocytes at sites of inflammation in relation to BCG-induced resistance to implants of syngeneic sarcoma in mice.
    Parr IB; Wheeler E; Alexander P
    J Natl Cancer Inst; 1977 Dec; 59(6):1659-66. PubMed ID: 303704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of mice after airborne infection with various strains of BCG.
    Lefford MJ
    Am Rev Respir Dis; 1978 Jan; 117(1):103-9. PubMed ID: 339795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of murine tumor with syngeneic antitumor serum plus BCG.
    Yamazaki M; Saito M; Abe S; Mizuno D
    Jpn J Exp Med; 1983 Feb; 53(1):27-32. PubMed ID: 6876475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antitumor activity of various forms of delayed-type hypersensitivity in mice.
    Lagrange PH; Thickstun PM
    J Natl Cancer Inst; 1979 Feb; 62(2):429-36. PubMed ID: 283275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.